Your browser doesn't support javascript.
loading
Chemical and neuropathological analyses of an Alzheimer's disease patient treated with solanezumab.
Roher, Alex E; Maarouf, Chera L; Kokjohn, Tyler A; Belden, Christine; Serrano, Geidy; Sabbagh, Marwan S; Beach, Thomas G.
Affiliation
  • Roher AE; Division of Clinical Education, Midwestern UniversityGlendale, AZ 85308; Division of Neurobiology, Barrow Neurological InstitutePhoenix, AZ 85013.
  • Maarouf CL; Laboratory of Neuropathology, Banner Sun Health Research Institute Sun City, AZ 85351.
  • Kokjohn TA; Department of Microbiology, Midwestern University Glendale, AZ 85308.
  • Belden C; Cleo Roberts Center for Clinical Research, Banner Sun Health Research Institute Sun City, AZ 85351.
  • Serrano G; Laboratory of Neuropathology, Banner Sun Health Research Institute Sun City, AZ 85351.
  • Sabbagh MS; Alzheimer's and Memory Disorders Division, Barrow Neurological Institute Phoenix, AZ 85013.
  • Beach TG; Laboratory of Neuropathology, Banner Sun Health Research Institute Sun City, AZ 85351.
Am J Neurodegener Dis ; 5(4): 158-170, 2016.
Article in En | MEDLINE | ID: mdl-27725918
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Neurodegener Dis Year: 2016 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Neurodegener Dis Year: 2016 Document type: Article